6533b7cffe1ef96bd12590c1
RESEARCH PRODUCT
The calm before the storm: a report from the International Liver Cancer Association Congress 2015 – part 2
Gennaro Gadaleta-caldarolaMaria ReigGian Carlo MazzaGiuseppe LombardiJean-charles NaultJean-charles NaultRodolfo SaccoGiovanni GalatiCarlo SaittaGiuseppe CabibboLuca Marzisubject
0301 basic medicineCancer Researchmedicine.medical_specialtyPathologysurvivalliver cancer03 medical and health sciences0302 clinical medicineInternal medicinestaging systemmedicineHCC; immunotherapy; liver cancer; management; prognosis; sorafenib; staging system; survival; trial design; Carcinoma Hepatocellular; Disease Management; Humans; Liver Neoplasms; Oncology; Cancer ResearchHumansHCCDisease management (health)Staging systembusiness.industryCarcinomaLiver NeoplasmsDisease ManagementHepatocellularGeneral MedicineHepatologymedicine.disease030104 developmental biologyOncologyFamily medicinetrial designsorafenib030211 gastroenterology & hepatologyimmunotherapyprognosisbusinessLiver cancermanagementdescription
International Liver Cancer Association Congress 2015, Paris, France, 4–6 September 2015 Since its creation 9 years ago, in 2007, the International Liver Cancer Association has focused on the multidisciplinary approach to liver cancer due to advances in hepatology science and care worldwide. In its 2015 annual conference, held on 4–6 September in Paris, France, the most recent progresses in the basic biology, management and treatment of liver cancer have been presented. This report, divided into two parts, introduces and critically reviews some of the most intriguing topics discussed at the meeting.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2016-02-01 | Future Oncology |